Three Automated Urine Analyzers Compared with Manual Microscopic Urinalysis
|
By LabMedica International staff writers Posted on 03 Mar 2021 |
|
Image: The iRICELL series combines urine chemistry and microscopy in a fully automated, walk-away workcell that is easy to use and maintain and optimizes and advances urinalysis and body fluid testing (Photo courtesy of Beckman Coulter).
Urinalysis is an essential screening test in clinical laboratories in order to diagnose and plan treatment for urinary tract infections, kidney disease and diabetes. Urinalysis includes visual examination, evaluation of chemical parameters and microscopic examination.
Microscopic examination is fundamental to urine analysis. This is a simple way to collect informative data, but it is also labor-intensive, time-consuming, and requires experienced staff for accurate results and interpretation. Several automated urine analyzers have been introduced for urine analysis in medical laboratories.
Clinical Medical Laboratorians at the Prince of Songkla University (Songkhla, Thailand) collected fresh 100 urine samples in preservative-free containers and transferred to four different test tubes for three automated urine analyzers without centrifuging and manual microscopy by three experienced medical technologists, independently using the same microscope slide.
The scientists assessed and compared the performance of the most common three automated urine analyzers: Cobas 6500 (Roche Diagnostics, Indianapolis, IN, USA); UN3000-111b (Sysmex Corporation, Kobe, Japan); and iRICELL 3000 (Beckman Coulter, Brea, CA, USA). The Cobas 6500 is a combination of two analyzers including the Cobas u601 which analyzes physical and chemical components, and the Cobas u701 which performs microscopic examinations. The UN3000-111b has two component analyzers in a single platform including a chemical component (UC-3500 analyzer) for analyzing the physical and chemical parts of urine and a fluorescence flow cytometry component (UF-5000 analyzer) for microscopic examination of sediments. The iRICELL 3000 is a combination of two component analyzers including a chemical component (iChemVELOCITY) and a microscopic examination component (iQ200).
The medical laboratorians reported that there was good correlation of urine physical and chemical analyses between the three analyzers with an overall concordance level of more than 80%. For sediment analysis, the degree of concordance between manual analysis and the three instruments was very good to good for white blood cells, red blood cells and epithelial cells, and moderate for bacteria. There were fair to good agreements between manual microscopy and the three instruments, Cobas 6500, UN3000-111b and iRICELL 3000, for casts (Cohen’s kappa 0.42, 0.38 and 0.62, respectively).
The authors concluded that the three automated urine analyzers showed similar performances and good correlation with manual microscopy. The results of this study indicate that automated urine analyzers could be used for initial urine testing to reduce high workloads and to save time, but manual microscopic analysis by experienced staff is still necessary to classify urine sediments for confirmation, especially in pathologic specimens. The study was published in the March, 2021 issue of the journal Practical Laboratory Medicine.
Related Links:
Prince of Songkla University
Roche Diagnostics
Sysmex Corporation
Beckman Coulter
Microscopic examination is fundamental to urine analysis. This is a simple way to collect informative data, but it is also labor-intensive, time-consuming, and requires experienced staff for accurate results and interpretation. Several automated urine analyzers have been introduced for urine analysis in medical laboratories.
Clinical Medical Laboratorians at the Prince of Songkla University (Songkhla, Thailand) collected fresh 100 urine samples in preservative-free containers and transferred to four different test tubes for three automated urine analyzers without centrifuging and manual microscopy by three experienced medical technologists, independently using the same microscope slide.
The scientists assessed and compared the performance of the most common three automated urine analyzers: Cobas 6500 (Roche Diagnostics, Indianapolis, IN, USA); UN3000-111b (Sysmex Corporation, Kobe, Japan); and iRICELL 3000 (Beckman Coulter, Brea, CA, USA). The Cobas 6500 is a combination of two analyzers including the Cobas u601 which analyzes physical and chemical components, and the Cobas u701 which performs microscopic examinations. The UN3000-111b has two component analyzers in a single platform including a chemical component (UC-3500 analyzer) for analyzing the physical and chemical parts of urine and a fluorescence flow cytometry component (UF-5000 analyzer) for microscopic examination of sediments. The iRICELL 3000 is a combination of two component analyzers including a chemical component (iChemVELOCITY) and a microscopic examination component (iQ200).
The medical laboratorians reported that there was good correlation of urine physical and chemical analyses between the three analyzers with an overall concordance level of more than 80%. For sediment analysis, the degree of concordance between manual analysis and the three instruments was very good to good for white blood cells, red blood cells and epithelial cells, and moderate for bacteria. There were fair to good agreements between manual microscopy and the three instruments, Cobas 6500, UN3000-111b and iRICELL 3000, for casts (Cohen’s kappa 0.42, 0.38 and 0.62, respectively).
The authors concluded that the three automated urine analyzers showed similar performances and good correlation with manual microscopy. The results of this study indicate that automated urine analyzers could be used for initial urine testing to reduce high workloads and to save time, but manual microscopic analysis by experienced staff is still necessary to classify urine sediments for confirmation, especially in pathologic specimens. The study was published in the March, 2021 issue of the journal Practical Laboratory Medicine.
Related Links:
Prince of Songkla University
Roche Diagnostics
Sysmex Corporation
Beckman Coulter
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
Vaginitis Test
Allplex Vaginitis Screening Assay
Latest Clinical Chem. News
- Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
- Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
- AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
- Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
- Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
- New Saliva Test Rapidly Identifies Paracetamol Overdose
- POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
- Screening Tool Detects Multiple Health Conditions from Single Blood Drop
- Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
- Rapid Drug Test to Improve Treatment for Patients Presenting to Hospital
- AI Model Detects Cancer at Lightning Speed through Sugar Analyses
- First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring
- New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
Channels
Molecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read more
Technology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
